Predict your next investment

Asset/Investment Management
cmsmezz.com

See what CB Insights has to offer

Investments

1

Portfolio Exits

1

About CMS Mezzanine

CMS Mezzanine Fund is a $40 million mezzanine fund focused on the lower middle market. Since its final close in 2009, the fund has deployed over $25 million in seven investments.

CMS Mezzanine Headquarter Location

Wynnewood, Pennsylvania,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest CMS Mezzanine News

BioPharm Communications Gets Boathouse and CMS Mezzanine Backing

Apr 19, 2012

BioPharm Communications Gets Boathouse and CMS Mezzanine Backing April 19, 2012 By Angela Sormani Boathouse Capital and CMS Mezzanine have backed BioPharm Communications. Headquartered in New Hope, PA, BioPharm is a medical communications and marketing agency specializing in non-personal, peer-to-peer solutions to the pharmaceutical and biotechnology industries. Boathouse and CMS invested $10.5 million in subordinated debt and equity in a Southfield Capital Advisors led recapitalization of BioPharm alongside management. BioPharm’s senior management will maintain a minority ownership position in the company. PRESS RELEASE Boathouse Capital and CMS Mezzanine are pleased to announce an investment in BioPharm Communications, LLC (“BioPharm”) on March 23, 2012. Headquartered in New Hope, PA, BioPharm is a leading medical communications and marketing agency that specializes in providing non-personal, peer-to-peer solutions to the pharmaceutical and biotechnology industries. BioPharm develops robust clinical content in collaboration with key opinion leaders and delivers it to healthcare practitioners through the company’s comprehensive suite of proprietary branded programs. BioPharm maximizes on-line and offline clinician engagements via its multi-channel “surround sound” delivery capabilities, including targeted direct mail, e-mail, web hosting, web banners/display advertising, search engine marketing, DVDs, mobile devices, selling kits, e-meetings and teleconferences. BioPharm leverages its experienced account managers, streamlined processes and extensive content development expertise across numerous therapeutic classes to deliver campaigns that generate industry leading engagements and returns on investment. Boathouse and CMS invested $10.5 million in subordinated debt and equity in a Southfield Capital Advisors led recapitalization of BioPharm alongside management. BioPharm’s senior management will continue in their current operating roles and will maintain a minority ownership position in the company. About Boathouse Capital Boathouse Capital is a lower middle market mezzanine debt and equity private equity firm in Wayne, PA. Boathouse Capital was founded in 2009 by Ken Jones, Bill Dyer, Steve Gord, and Chong Moua and has $120 million of capital under management. Boathouse Capital has deployed more than $60 million in ten portfolio companies to date. www.boathousecapital.com About CMS Mezzanine CMS Mezzanine Fund is a $40 million mezzanine fund focused on the lower middle market. Since its final close in 2009, the fund has deployed over $25 million in seven investments. The fund is based in Wynnewood, PA. www.cmsmezz.com About Southfield Capital Advisors Founded in 2005, Southfield Capital provides capital for majority recapitalizations and management-led buyouts of lower middle-market businesses. The firm makes control investments in North American companies generating $5-$15 million in EBITDA with proven business models, attractive growth and profitability trends and solid leadership. Headquartered in Greenwich, CT, Southfield Capital also has offices in Alexandria, VA and Louisville, KY. © 2015 Buyouts Insider / Argosy Group LLC

CMS Mezzanine Investments

1 Investments

CMS Mezzanine has made 1 investments. Their latest investment was in BioPharm Communications as part of their Private Equity on April 4, 2012.

CBI Logo

CMS Mezzanine Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

4/19/2012

Private Equity

BioPharm Communications

$10.5M

Yes

1

Date

4/19/2012

Round

Private Equity

Company

BioPharm Communications

Amount

$10.5M

New?

Yes

Co-Investors

Sources

1

CMS Mezzanine Portfolio Exits

1 Portfolio Exit

CMS Mezzanine has 1 portfolio exit. Their latest portfolio exit was BioPharm Communications on June 09, 2016.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

6/9/2016

Acquired

$99M

1

Date

6/9/2016

Exit

Acquired

Companies

Valuation

$99M

Acquirer

Sources

1

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.